tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

EW Stock Latest News

Edwards Lifesciences price target lowered to $85 from $95 at Stifel
The FlyEdwards Lifesciences price target lowered to $85 from $95 at Stifel
11d ago
EW
Edwards Lifesciences management to meet with Piper Sandler
PremiumThe Fly
Edwards Lifesciences management to meet with Piper Sandler
25d ago
EW
Edwards Lifesciences: Strategic Positioning and Growth Potential Drive Buy Rating Amid TAVR Market Expansion
PremiumRatings
Edwards Lifesciences: Strategic Positioning and Growth Potential Drive Buy Rating Amid TAVR Market Expansion
1M ago
EW
Edwards Lifesciences Enters Accelerated Share Repurchase Agreement
PremiumCompany Announcements
Edwards Lifesciences Enters Accelerated Share Repurchase Agreement
1M ago
8K
EW
Edwards Lifesciences announces $500M accelerated share repurchase
PremiumThe Fly
Edwards Lifesciences announces $500M accelerated share repurchase
2M ago
EW
Edwards Lifesciences’ TRISCEND II Trial: A Game-Changer in Tricuspid Valve Treatment?
PremiumCompany AnnouncementsEdwards Lifesciences’ TRISCEND II Trial: A Game-Changer in Tricuspid Valve Treatment?
2M ago
EW
Edwards Lifesciences’ ENCIRCLE Trial: A New Hope for Mitral Regurgitation Patients
Premium
Company Announcements
Edwards Lifesciences’ ENCIRCLE Trial: A New Hope for Mitral Regurgitation Patients
2M ago
EW
Edwards Lifesciences’ TRISCEND Study: A Game-Changer in Tricuspid Valve Replacement?
Premium
Company Announcements
Edwards Lifesciences’ TRISCEND Study: A Game-Changer in Tricuspid Valve Replacement?
2M ago
EW
Edwards Lifesciences Advances with SAPIEN X4 Heart Valve Study
PremiumCompany Announcements
Edwards Lifesciences Advances with SAPIEN X4 Heart Valve Study
2M ago
EW
Hold Rating for Edwards Lifesciences Amid Uncertainty in JenaValve Deal and Adjusted EPS Guidance
PremiumRatings
Hold Rating for Edwards Lifesciences Amid Uncertainty in JenaValve Deal and Adjusted EPS Guidance
2M ago
EW
Edwards Lifesciences’ ALT-FLOW II Trial: A Key Update for Heart Failure Treatment
PremiumCompany Announcements
Edwards Lifesciences’ ALT-FLOW II Trial: A Key Update for Heart Failure Treatment
2M ago
EW
Edwards Lifesciences: Hold Rating Maintained Amid JenaValve Acquisition Delay
PremiumRatings
Edwards Lifesciences: Hold Rating Maintained Amid JenaValve Acquisition Delay
2M ago
EW
Edwards Lifesciences: Strong Growth Prospects Amid Regulatory Challenges
PremiumRatingsEdwards Lifesciences: Strong Growth Prospects Amid Regulatory Challenges
2M ago
EW
JenaValve to join Edwards to defend case against FTC challenge
Premium
The Fly
JenaValve to join Edwards to defend case against FTC challenge
2M ago
EW
FTC Blocks Edwards Lifesciences’ Acquisition of JenaValve
Premium
Company Announcements
FTC Blocks Edwards Lifesciences’ Acquisition of JenaValve
2M ago
8K
EW
Edwards Lifesciences raises FY25 adjusted EPS view to high-end of $2.45-$2.55
PremiumThe Fly
Edwards Lifesciences raises FY25 adjusted EPS view to high-end of $2.45-$2.55
2M ago
EW
Edwards to pursue regulatory approval after FTC action to block JenaValve deal
PremiumThe Fly
Edwards to pursue regulatory approval after FTC action to block JenaValve deal
2M ago
EW
Edwards Lifesciences’ SAPIEN 3 Valve Study: A Real-World Evaluation
PremiumCompany Announcements
Edwards Lifesciences’ SAPIEN 3 Valve Study: A Real-World Evaluation
2M ago
EW
Edwards Lifesciences’ PASCAL System: A Promising Update in Tricuspid Valve Repair
PremiumCompany Announcements
Edwards Lifesciences’ PASCAL System: A Promising Update in Tricuspid Valve Repair
2M ago
EW
Edwards Lifesciences’ SAPIEN 3 Study: A Market Game-Changer?
PremiumCompany AnnouncementsEdwards Lifesciences’ SAPIEN 3 Study: A Market Game-Changer?
2M ago
EW
Edwards Lifesciences’ Pivotal Trial: A Game-Changer for Tricuspid Valve Repair?
Premium
Company Announcements
Edwards Lifesciences’ Pivotal Trial: A Game-Changer for Tricuspid Valve Repair?
2M ago
EW
Sarepta upgraded, Tapestry downgraded: Wall Street’s top analyst calls
Premium
The Fly
Sarepta upgraded, Tapestry downgraded: Wall Street’s top analyst calls
2M ago
CF
EW

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >